Abbreviations: CLA, conjugated linoleic acid; FAME, fatty acid methyl ester; GC, gas chromatography; HFA, hydroxy fatty acid;. LA, linoleic acid (cis-9,cis-12-18:2); LI, linoleate isomerase; SA, stearic acid (18:0); VA, vaccenic acid (trans-11-18:1).
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Linoleic acid (LA; cis -9,cis-12-18: 2) is metabolised in the human colon via 8 conjugated linoleic acid (CLA; mainly cis-9,trans-11-18:2, LA) to vaccenic acid (VA; 9 trans- 11-18:1) , both of which are considered to be beneficial for health (5, 11, 27, 28, 10 31, 41), then to stearic acid (18:0) (17, 26) . A similar pathway occurs in the rumen (12, 11 20) , where this process, commonly known as biohydrogenation, carries important 12 implications for the fatty acid composition of meat and milk (22, 38). The 13 microbiology of biohydrogenation in the rumen has received a great deal of attention 14 (12, 32, 40, 42) , but similar investigations have not been carried out for the human 15 intestinal microbiota. The aims of the present study were therefore to identify human 16 gut bacteria that can undertake fatty acid biohydrogenation, and to assess their likely 17 importance in the mixed intestinal ecosystem. It emerged that Roseburia spp. were 18 probably of greatest importance, some species metabolising LA by the same pathway 19 found in ruminal bacteria (20, 32), while others formed a hydration product that is a 20 precursor of CLA in the mixed community. 21
Thirty bacterial strains (2 lactobacilli, 1 lactococcus, 5 propionibacteria, 3 22 bifidobacteria and 19 strains of the low G+C Clostridium cluster) isolated from or 23 related to bacteria found in the human large intestine were studied for their ability to 24 metabolise LA (Table 1 ). The bacteria were grown either in the liquid form of 25 anaerobic basal M2 medium (13) or in the same medium supplemented with 50 µg/ml 26 LA. For labelling experiments the medium was prepared using deuterium oxide, to 27 provide an enrichment in the medium water of around 50%. Linoleate isomerase 28 activity was measured in bacteria grown on unsupplemented M2 medium by the 29 method described by Wąsowska et al. (43) . Extraction and derivatization of the total 30 fatty acids to fatty acid methyl esters (FAME) and identification methods were similar 31
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on August 30, 2017 by guest http://jb.asm.org/ Downloaded from HFA with the first ten bonds saturated. When R. intestinalis L1-952 was grown in the 57 presence of 50 µg/ml LA and deuterium oxide, the two major peaks were shifted to 58 ions 171 and 203 (Fig. 1B) . This shift corresponded to an addition of deuterium atoms 59 at the double bond between carbons 9 and 10, suggesting that hydration occurred on 60 this double bond (Fig. 1B) . The location of the double bond could not be determined 61 by analysis of the FAME. However, the signature masses of 201 and 294 identified in 62 10-hydroxy-cis-12-18:1 by Schroepfer et al. (37) were present in the FAME spectrum. 63
This information, together with purely biochemical considerations and comparison of 64 the elution time of the FAME with that of ricinoleic acid (12-hydroxy-cis-9-18:1) 65 indicated that the product was most likely 10-hydroxy-cis-12-18:1. 66 M2-modified medium prepared from the culture supernatant of R. intestinalis 67 L1-952 initially contained 5 µg/ml LA and 25 µg/ml HFA. The main fatty acids 68 produced during incubation with diluted feces were cis-9,trans-11-18:2, VA and SA 69 (Fig. 2) . After few hours, LA was almost completely metabolised, but the synthesis of 70 CLA, VA and SA continued and corresponded to the disappearance of HFA (Fig. 2) . 71
Thus, it was concluded that HFA is a precursor of cis-9,trans-11-18:2 in the mixed 72 community. None of the pure cultures examined here metabolised the HFA further. 73
Animal studies and clinical trials indicate that CLA may be useful in improving 74 human health (5, 27, 31). The uptake of CLA formed in the intestine seems to be 75 minor (17) . However, local effects on gut tissue might be anticipated. It is now well 76 established that CLA have anti-proliferative and anti-inflammatory effects on 77 colonocytes (4, 19), so the provision of CLA in the intestinal lumen would be 78 considered beneficial, particularly for inflammatory bowel disease, such as ulcerative 79 colitis and Crohn's disease (10) . Bacteria from other ecosystems and from food 80 products, but which are also found in the human gut, including strains of 81 we show that the more abundant bacterial species belonging to clostridial clusters IV 84
and XIVa also metabolise LA at among the fastest rates of all bacteria investigated, 85 forming products that can be precursors of CLA (Fig. 3) . Given the greater abundance 86
of Clostridium-like bacteria present in the human intestinal microbiota (9) -87 lactobacilli, propionibacteria, bifidobacteria numbers are low, less than 5 % of the total 88 microbiota (2, 21) -it may be deduced that LA metabolism by this major group will be 89 quantitatively more important than that of the Lactobacillus, Propionibacterium and 90
Bifidobacterium groups. 91
The discovery that HFA is a precursor of cis-9,trans-11-18:2 in the mixed 92 intestinal community is also new, leading to a likely scheme of CLA formation as 93 described in Fig. 3 . A similar importance of HFA was proposed for a Lactobacillus sp., 94 involving a hydration/dehydration process (30). No similar role for HFA has been 95 postulated for bacteria in the rumen, where biohydrogenation is a quantitatively highly 96 important activity (12, 32) . 97
The final product of LA metabolism by mixed fecal microbiota was shown here 98 to be stearic acid, as already shown by Howard and Henderson (14) 
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